SEC Form 4 · accession 0001179110-16-020685
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Severino
Officer — EVP, R&D and CSO
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par value | Feb 29, 2016 | F | 8,053 | $56.00 | D | 164,856 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy) | $54.86 | Feb 18, 2016 | A | 91,990 | A | Feb 18, 2017 | Feb 17, 2026 | Common stock | 91,990 | 91,990 | D |